Status:
COMPLETED
Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCF
Lead Sponsor:
French Cardiology Society
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Infection Viral
Infection, Hospital
Eligibility:
All Genders
18+ years
Brief Summary
The COVID-19 pandemic of SARS CoV2 (Severe Acute Respiratory Syndrome, COVID-19) infection, which is currently evolving in France, raises many questions about the clinical and biological profile of in...
Detailed Description
This study is observational, multicenter and retrospective, and is conducted in hospitals in France. Clinical data relating to history, comorbidities, risk factors, previous treatments, treatments du...
Eligibility Criteria
Inclusion
- \- Patients hospitalized in cardiology unit or medicine conventional sector with diagnosis of COVID-19 (positive PCR (Polymerase Chain Reaction) or diagnosis presumed by the clinical and radiographic picture)
Exclusion
- Minors
- Pregnant women
Key Trial Info
Start Date :
April 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 21 2020
Estimated Enrollment :
2878 Patients enrolled
Trial Details
Trial ID
NCT04344327
Start Date
April 10 2020
End Date
April 21 2020
Last Update
April 28 2020
Active Locations (23)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU d'Amiens
Amiens, France, 80054
2
CHU Annecy
Annecy, France, 74374
3
CHU de Bordeaux
Bordeaux, France, 33404
4
CHU de Caen
Caen, France, 14033